Immediate Impact
2 by Nobel laureates 3 from Science/Nature 51 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
2024 Standout
Works of Katrien Verschueren being referenced
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
2019
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Katrien Verschueren | 97 | 143 | 16 | 114 | 7 | 324 | |
| Tal Sapir | 34 | 76 | 9 | 142 | 10 | 322 | |
| M Canova | 29 | 31 | 25 | 155 | 5 | 358 | |
| H Hagberg | 21 | 52 | 99 | 43 | 12 | 303 | |
| Erika Chang | 41 | 139 | 10 | 78 | 9 | 315 | |
| R. Zigelman | 25 | 46 | 36 | 158 | 8 | 359 | |
| F Navaux | 37 | 59 | 64 | 133 | 9 | 353 | |
| Elizabeth Vogt | 20 | 116 | 3 | 122 | 7 | 364 | |
| Tiziana Bertero | 13 | 138 | 4 | 51 | 11 | 274 | |
| Jeff Reid | 58 | 14 | 36 | 218 | 5 | 362 | |
| Ahmed T. Kurdi | 21 | 42 | 81 | 121 | 10 | 342 |
All Works
Loading papers...